Clinical Trial Update: A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase [Phase 4]

View source ↗

Summary

Phase 4 real-world study comparing flumatinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia Chronic Phase

Drugs mentioned

• Flumatinib (flumatinib)
• Imatinib (imatinib)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: CML, Chronic Phase | Phase 4 | Status: NOT_YET_RECRUITING